Air Pollution May Lead to a Key Alzheimer’s Biomarker in the Brain
Air pollution — a major cause of global warming — has been on the forefront of the debate regarding climate change. Now, as we…
Air pollution — a major cause of global warming — has been on the forefront of the debate regarding climate change. Now, as we…
Amid the growing burden of Alzheimer’s in the U.S., researchers aim to better understand the relationship between the disease and the places people live….
Sharon Elin of Mechanicsville, Virginia had noticed that, as her brother Chad’s memory declined, he was becoming increasingly restless, spending hours fiddling about, carrying…
The first ever commercial Alzheimer’s blood test is on the market. It’s big progress. Some experts have reservations because it hasn’t yet secured FDA…
As part of our BrainTalk series, Being Patient spoke with Jack Price, professor of developmental neurobiology at King’s College London, about how stem cell…
The idea that anxiety somehow foreshadows Alzheimer’s is not new: We have seen it in, for example, 2018 findings that increased anxiety corresponded with…
As we age, memories of long past events become more important, especially with each passing decade of late midlife and old age. Studies show…
This article was written during the first holiday season of the novel coronavirus pandemic, in 2020. Being Patient speaks with experts about safe ways…
Alzheimer’s disease is more prevalent among Black Americans than among white Americans. By some estimates, it is 14% more common among Black Americans; by others, their…
While researchers have known that the ApoE4 genetic variant is the strongest genetic risk factor for Alzheimer’s and related dementias, this finding is largely…
Researchers in Germany studied the effects of ApoE4, the best known genetic factor for Alzheimer’s Disease, on the brains of 82 young adults —…
A prima ballerina with Alzheimer’s disease remembers Tchaikovsky’s “Swan Lake;” details of her past as a dancer remain a mystery. The ability of music…
A nationwide September study revealed that many Americans lack the understanding of dementia and Alzheimer’s disease, even though Alzheimer’s is one of the leading causes…
In a surprising turn of events, the Advisory Committee of experts on Biogen’s experimental Alzheimer’s drug aducanumab recommended against FDA approval of the drug…
UPDATE: 3 March 2024, 8:19 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…